FTP036

Organization name

Labomar S.p.A.

SRN

IT-MF-000007965

Manufacturer status

Active

Certificate health across this manufacturer's portfolio.

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  • Oral use. • Do not use in the case of known incompatibility with the single ingredients of the product. • Do not take if hypersensitive or allergic to any of the ingredients. • Even though no side effects are known, it is advisable not to use the product during pregnancy or in the first few months of breastfeeding. In any case, first consult your own doctor. • The product is not intended for children. • In the event of simultaneous pharmacological treatments, consult your doctor before using the device. • The expiry date refers to the product correctly stored in intact packaging. • Do not exceed the recommended daily dose. • Do not use the product after the expiry date shown on the package. • Keep out of the reach and sight of children. SIDE EFFECTS: No side effects related to the use of HEPILOR are known. If side effects are noticed, stop use and see a doctor.

Primary placement in Italy; available across 1 country total.

Trade name

not provided

UDI-DI code

D-FTP036ES

Basic UDI-DI

B-FTP036ES

Reference / catalog number

FTP036

Issuing entity

EUDAMED

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

Hepilor capsule is a medical device designed for the protection of gastrointestinal mucosa.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• G0401ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS